<DOC>
	<DOC>NCT02772354</DOC>
	<brief_summary>To evaluate the effectiveness and safety of catheter ablation of frequent symptomatic PVCs in the pediatric population as first-line therapy compared with antiarrhythmic drugs.</brief_summary>
	<brief_title>Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population</brief_title>
	<detailed_description />
	<mesh_term>Ventricular Premature Complexes</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Symptomatic, frequent, premature ventricular complexes (more than 10,000 according to the 24 hour Holter ECG) Antiarrhythmic therapy before inclusion Structural heart pathology requiring surgical correction; Premature ventricular complexes associated with structural heart disease; Previously performed radiofrequency ablation due to premature ventricular complexes.</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pediatric population, ablation</keyword>
</DOC>